Compound 84
Identifiers
- Canonical SMILES:
CN1c2ncnn2[C@H](C2=C1c1cc(C)c(F)cc1O[C@@H]2c1ccc(Br)cc1)c1ccc(Br)cc1
- InChi:
InChI=1S/C26H19Br2FN4O/c1-14-11-19-21(12-20(14)29)34-25(16-5-9-18(28)10-6-16)22-23(15-3-7-17(27)8-4-15)33-26(30-13-31-33)32(2)24(19)22/h3-13,23,25H,1-2H3/t23-,25+/m0/s1
- InChiKey:
SPIVDVDFJKYYRU-UKILVPOCSA-N
External links
44550016 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 6.32 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 579.99 g/mol | |||
HBA | 5 | |||
HBD | 0 | |||
HBA + HBD | 5 | |||
AlogP | 7.16 | |||
TPSA | 43.18 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4475 | BMS-394136 | DB12067 | |
0.3754 | GDC-0927 | DB14934 | |
0.3704 | Parsaclisib | DB14867 | |
0.3471 | Posaconazole | DB01263 | |
0.3462 | Naldemedine | DB11691 | |
0.3414 | Desvancosaminyl vancomycin | DB04529 | |
0.3402 | (4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium | DB02673 | |
0.3386 | Vancomycin | DB00512 | |
0.3380 | LY-2881835 | DB15046 | |
0.3342 | Balhimycin | DB04111 | |
0.3333 | 4-epi-vancosaminyl derivative of vancomycin | DB04431 | |
0.3323 | Rocacetrapib | DB15437 | |
0.3292 | Oritavancin | DB04911 | |
0.3283 | Telavancin | DB06402 | |
0.3279 | E-2012 | DB05171 |